Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Chemesis International Inc CADMF

Healthcare Drug Manufacturers - Major Cannabis
"Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently operating within California, Puerto Rico, and Colombia. Chemesis is developing a strong foothold in key markets, from cultivation to manufacturing, distribution and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost-effective production and distribution of its products. In addition, Chemesis leverages exclusive brands and partnerships and uses the highest q


OTCPK:CADMF - Post by User

Chemesis International Inc > revenue projections updated
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(994)
•••
Comment by dart321on Mar 20, 2019 8:08pm
35 Views
Post# 29514239

RE:RE:RE:RE:revenue projections updated

RE:RE:RE:RE:revenue projections updated and as per their 2020 numbers by June 30th 2020 they say sales of 78.9 million U.S. that's 15 months one week away.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities